Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Anna
Anna graduated from Harvard University with a BA in English and a minor in Linguistics and Language Theory. While at Harvard, she was a curriculum editor for the Mamelodi Initiative in South Africa.
Eduardo
Eduardo earned his BS in Brain & Cognitive Sciences from MIT (Phi Beta Kappa, 4.9/5.0 GPA). He is currently pursuing his MD/PhD from the Harvard-MIT Health Sciences and Technology (HST) Program.